Ergothioneine Market Size & Share Analysis - Growth Trends and Forecast (2027 - 2032)

The Ergothioneine Market Report is Segmented by Form (Powder, Liquid), Source (Mushrooms, Algae, Bacteria and Engineered Microorganisms, Yeast), Application (Dietary Supplements, Functional Food and Beverages, Pharmaceuticals, Personal Care and Cosmetics, Animal Nutrition), and Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Ergothioneine Market Size and Share

Ergothioneine Market Size
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Ergothioneine Market Analysis by Mordor Intelligence

The ergothioneine market size is expected to grow from USD 99.27 million in 2026 to USD 110.71 million in 2027 and is forecast to reach USD 226.67 million by 2032 at 15.41% CAGR over 2027-2032. The market is supported by a clinical evidence base that links the compound with cognitive health, sleep, mitochondrial function, and healthy aging. Its uptake through the OCTN1 transporter gives manufacturers a distinct scientific basis for positioning it against conventional antioxidant ingredients. Precision fermentation is changing the supply outlook by reducing dependence on mushroom extraction and supporting food and beverage formulations. Regulatory clearances in the United States, Europe, and parts of Asia-Pacific remain central to commercial access, because they define permitted formats and use levels. Companies with clinical data, fermentation capabilities, and completed regulatory filings hold a stronger position as the category moves into larger consumer channels.

Key Report Takeaways

  • By form, powder held 54.76% of the ergothioneine market share in 2026, while liquid is projected to grow at a 16.91% CAGR through 2032.

  • By source, mushrooms accounted for 81.18% of the ergothioneine market share in 2026, while bacteria and engineered microorganisms are projected to expand at a 16.33% CAGR through 2032.

  • By application, dietary supplements commanded 41.37% of the ergothioneine market size in 2026, while functional food and beverages are forecast to advance at a 16.56% CAGR through 2032.

  • By geography, North America held 34.76% of the ergothioneine market share in 2026, while Asia-Pacific is projected to grow at a 16.78% CAGR through 2032.

Note: Market numbers in this report are based on Mordor Intelligence's proprietary estimation framework, which combines nine months of actuals with Q4 projections for base year 2026.

Ergothioneine Market Segment Analysis

By Form:

Liquid Formats Extend Use Beyond Capsules

By form, powder accounted for the largest share of the ergothioneine market, representing 54.76% in 2026. Its dominance is primarily supported by its longer shelf life, storage stability, and ease of incorporation into various formulations. Powdered ergothioneine is widely preferred by dietary supplement manufacturers due to its suitability for capsules, tablets, and powdered nutritional blends. Its concentrated nature also allows manufacturers to achieve precise ingredient dosages across different product formulations. Additionally, powder offers greater convenience in transportation, handling, and bulk storage compared to liquid formulations.

The liquid segment of the ergothioneine market is projected to register the fastest growth, at a CAGR of 16.91% through 2032. Its growth is driven by increasing demand for convenient and ready-to-consume nutritional formulations. Liquid ergothioneine can be incorporated into functional beverages, liquid dietary supplements, and nutritional shots, expanding its potential application base. The format also eliminates the need for consumers to dissolve or mix powdered ingredients before consumption. Additionally, liquid formulations offer flexibility for manufacturers developing combination products containing antioxidants and other functional ingredients.

Need more granular breakdown of segment shares?

Get tailored market insights for your requirements.

Ergothioneine Market Share by Form, 2026
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Ergothioneine Market Share by Form, 2026

By Source:

Microbial Production Changes the Long-Term Supply Mix

By source, mushrooms accounted for the largest share of the ergothioneine market, representing 81.18% in 2026. Their dominance is primarily attributed to their naturally high ergothioneine content compared to several other dietary sources. Certain mushroom varieties, particularly shiitake, oyster, and king oyster mushrooms, are recognized as rich sources of this antioxidant compound. The established use of mushroom-derived ergothioneine also supports its adoption among dietary supplement, functional food, and nutraceutical manufacturers.

Bacteria and engineered microorganisms are projected to register the fastest growth in the ergothioneine market, expanding at a CAGR of 16.33% through 2032. Growth in this segment is driven by increasing investments in microbial fermentation and biotechnology-based production processes. Engineered microorganisms offer opportunities for controlled ergothioneine production by optimizing microbial strains and fermentation conditions. Compared to conventional extraction from mushrooms, microbial production can provide greater consistency in product quality and help reduce dependence on agricultural raw material availability.

By Application:

Supplements Lead While Food and Beverage Use Expands

By application, dietary supplements accounted for the largest share of the ergothioneine market, representing 41.37% in 2026. The segment's dominance is primarily driven by growing consumer awareness of oxidative stress and the role of antioxidants in supporting cellular health. Ergothioneine is increasingly incorporated into dietary supplement formulations due to its ability to protect cells against oxidative damage. Its specific cellular uptake mechanism through the OCTN1 transporter further strengthens its positioning as a functional ingredient in nutritional products. Supplement manufacturers are incorporating ergothioneine into capsules, tablets, and powdered formulations, often alongside other antioxidants and vitamins.

Functional food and beverages are projected to register the fastest growth in the ergothioneine market, expanding at a CAGR of 16.56% through 2032. Growth is supported by increasing consumer demand for foods and beverages that offer health benefits beyond basic nutrition. Ergothioneine's antioxidant properties make it an attractive functional ingredient for manufacturers developing products targeting cellular protection and overall wellness. Its incorporation into functional beverages, fortified foods, nutritional drinks, and wellness shots is creating new commercial opportunities.

Segment this market the way your business does.

Get tailored market insights for your requirements.

Ergothioneine Market Share by Application, 2026
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Geography Analysis

North America

By geography, North America accounted for the largest share of the ergothioneine market, representing 34.76% in 2026. The region's dominance is supported by growing consumer awareness of antioxidant ingredients and their potential role in cellular health and healthy ageing. Increasing demand for premium dietary supplements and nutraceutical products is encouraging manufacturers to incorporate ergothioneine into their formulations. The presence of established nutraceutical companies, ingredient suppliers, and biotechnology firms further supports regional market development. Additionally, rising interest in preventive healthcare, longevity, and functional nutrition is strengthening demand for science-backed bioactive ingredients.

Asia-Pacific

Asia-Pacific is projected to register the fastest growth in the ergothioneine market, expanding at a CAGR of 16.78% through 2032. Growth is driven by increasing consumer awareness of preventive healthcare, antioxidant nutrition, and healthy ageing across major regional economies. Rising disposable incomes and expanding middle-class populations are supporting expenditure on dietary supplements and functional food products. The region's established mushroom cultivation industry also provides opportunities for sourcing ergothioneine from natural raw materials. Additionally, growing investments in biotechnology, microbial fermentation, and functional ingredient manufacturing are supporting the development of alternative production methods.

Europe, South America, and Middle East and Africa

Europe operates under the European Food Safety Authority’s Novel Food authorization framework, including EU 2017/1281 and Regulation 2017/2470. This framework permits L-ergothioneine in adult dietary supplements up to 30 mg per day and permits defined use in alcohol-free beverages, cereal bars, milk products, and chocolate confectionery. The European model places compliance factors at the center of formulation and labeling choices. Germany’s Federal Office of Consumer Protection and Food Safety reconstituted its food-medicine boundary expert commission in March 2025, which is relevant to high-dose products positioned between supplements and pharmaceuticals.South America is an emerging channel centered on Brazil and Argentina, where cross-border e-commerce has built consumer familiarity ahead of wider domestic rules. Middle East and Africa remain early-stage markets, with the United Arab Emirates serving as a regional distribution hub. Premium consumers in the Gulf Cooperation Council provide an entry point for globally compliant brands.

Ergothioneine Market Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

Market Concentration

Ergothioneine Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

The ergothioneine market is highly consolidated, with a relatively small group of established manufacturers and specialized ingredient suppliers accounting for a significant share of the overall market. Competition is primarily driven by production capabilities, extraction technologies, product purity, supply consistency, and the ability to develop cost-effective manufacturing processes. Blue California’s ErgoActive holds an established position through precision fermentation and its FDA-notified GRAS status. Its clinical program includes a peer-reviewed 147-participant randomized trial, which supports evidence-based differentiation.

Shanghai EGT Synbio and GeneIII Biotech represent major competition from China’s synthetic biology suppliers. GeneIII’s GRAS notification and stated 150 mg per 100 g use level strengthen its position in food, protein, and nutrition powder applications. Tetrahedron S.A. has a distinctive European position through Novel Food authorization. Conagen and Anthem Biosciences bring fermentation expertise that becomes more relevant as biosynthesis expands.

GeneIII has pursued a strategy that combines fermentation production, regulatory clearance, and clinical research. The company stated that it uses proprietary Bacillus chromosome-editing technologies and holds 33 core patents. EGT Synbio has also focused on a fermentation-based ingredient that can serve supplement and food formats. These actions show that regulatory readiness and proof of performance are becoming more important than distributor scale alone. They also raise the requirements for smaller suppliers that compete mainly on price.

Ergothioneine Industry Leaders

  1. Shanghai EGT Synbio Group Co., Ltd.

  2. GENEIII Biotechnology Co., Ltd.

  3. Blue California

  4. Conagen, Inc.

  5. Comhony Biotech Co., Ltd.

  6. *Disclaimer: Major Players sorted in no particular order

Ergothioneine Market Companies Covered in this Report

  • Shanghai EGT Synbio Group Co., Ltd.
  • GENEIII Biotechnology Co., Ltd.
  • Blue California
  • Tetrahedron S.A.
  • Conagen, Inc.
  • Comhony Biotech Co., Ltd.
  • Anthem Biosciences Limited
  • Changzhou Kansenbio Technology Co., Ltd.
  • Sichuan Benepure Pharmaceutical Co., Ltd.
  • Suzhou Ryway Biotech Co., Ltd.
  • Xi'an Biof Bio-Technology Co., Ltd.
  • Xi'an Healthway Biotech Co., Ltd.
  • Xi'an Land Nutra Co., Ltd.
  • Shanghai Natural Biotechnology Co., Ltd.
  • EffePharm (Shanghai) Co., Ltd.
  • Shaanxi Pioneer Biotech Co., Ltd.
  • Natural Field Inc.
  • Yanggu Huatai Health Tech Co., Ltd.
  • Mironova Labs
  • NAGASE & CO., LTD.

Recent Industry Developments in Ergothioneine Market

  • January 2026: GENEIII announced that its fermentation-produced L-ergothioneine received a favourable US FDA GRAS determination under GRN 1270. The ingredient was cleared for specified food and beverage applications, including nutritional powders, beverages, protein bars, and confectionery, at notified use levels. The development supports the commercialization of microbial fermentation-derived ergothioneine in the United States market.
  • April 2025: Jiangsu GeneIII Bio-Tec Co., Ltd. completed a RMB 100 million (approximately USD 13.8 million) Pre-A financing round led by JAFCO Asia with Kunquan Capital as financial advisor, earmarked for upgrading ergothioneine raw-material production lines, expanding end-consumer product categories, and building an international standards certification system.
  • March 2025: EGT Synbio's Dr.Ergo® Ergothioneine received an FDA no-objection letter for GRAS Notice GRN 001191, marking the second US GRAS for ergothioneine, produced via a patented full enzymatic fermentation process licensed from the Chinese Academy of Science with NSF GMP, HACCP, HALAL, and ICH-guideline-aligned quality certifications.

Table of Contents for Ergothioneine Industry Report

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET LANDSCAPE

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising demand for antioxidant ingredients
    • 4.2.2 Growing focus on healthy aging and longevity
    • 4.2.3 Expanding applications in dietary supplements
    • 4.2.4 Increasing use of ergothioneine in anti-aging skincare
    • 4.2.5 Growing incorporation into functional foods and beverages
    • 4.2.6 Growing demand for naturally derived bioactive ingredients
  • 4.3 Market Restraints
    • 4.3.1 High production and manufacturing costs
    • 4.3.2 Limited availability of natural sources
    • 4.3.3 Complexities in Large-Scale Production
    • 4.3.4 Inconsistent raw material quality and standardization
  • 4.4 Supply Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter's Five Forces Analysis
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Buyers
    • 4.7.3 Bargaining Power of Suppliers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Competitive Rivalry

5. MARKET SIZE AND GROWTH FORECASTS (VALUE)

  • 5.1 By Form
    • 5.1.1 Powder
    • 5.1.2 Liquid
  • 5.2 By Source
    • 5.2.1 Mushrooms
    • 5.2.2 Algae
    • 5.2.3 Bacteria and Engineered Microorganisms
    • 5.2.4 Yeast
  • 5.3 By Application
    • 5.3.1 Dietary Supplements
    • 5.3.2 Functional Food and Beverages
    • 5.3.3 Pharmaceuticals
    • 5.3.4 Personal Care and Cosmetics
    • 5.3.5 Animal Nutrition
    • 5.3.6 Other Applications
  • 5.4 By Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.1.4 Rest of North America
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Spain
    • 5.4.2.5 Italy
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 India
    • 5.4.3.3 Japan
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 South America
    • 5.4.4.1 Brazil
    • 5.4.4.2 Argentina
    • 5.4.4.3 Rest of South America
    • 5.4.5 Middle East and Africa
    • 5.4.5.1 United Arab Emirates
    • 5.4.5.2 South Africa
    • 5.4.5.3 Saudi Arabia
    • 5.4.5.4 Rest of Middle East and Africa

6. COMPETITIVE LANDSCAPE

  • 6.1 Market Concentration
  • 6.2 Strategic Moves
  • 6.3 Market Ranking Analysis
  • 6.4 Company Profiles (includes Company Highlights, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
    • 6.4.1 Shanghai EGT Synbio Group Co., Ltd.
    • 6.4.2 GENEIII Biotechnology Co., Ltd.
    • 6.4.3 Blue California
    • 6.4.4 Tetrahedron S.A.
    • 6.4.5 Conagen, Inc.
    • 6.4.6 Comhony Biotech Co., Ltd.
    • 6.4.7 Anthem Biosciences Limited
    • 6.4.8 Changzhou Kansenbio Technology Co., Ltd.
    • 6.4.9 Sichuan Benepure Pharmaceutical Co., Ltd.
    • 6.4.10 Suzhou Ryway Biotech Co., Ltd.
    • 6.4.11 Xi'an Biof Bio-Technology Co., Ltd.
    • 6.4.12 Xi'an Healthway Biotech Co., Ltd.
    • 6.4.13 Xi'an Land Nutra Co., Ltd.
    • 6.4.14 Shanghai Natural Biotechnology Co., Ltd.
    • 6.4.15 EffePharm (Shanghai) Co., Ltd.
    • 6.4.16 Shaanxi Pioneer Biotech Co., Ltd.
    • 6.4.17 Natural Field Inc.
    • 6.4.18 Yanggu Huatai Health Tech Co., Ltd.
    • 6.4.19 Mironova Labs
    • 6.4.20 NAGASE & CO., LTD.

7. MARKET OPPORTUNITIES AND FUTURE OUTLOOK

Global Ergothioneine Market Report Scope

Ergothioneine (EGT) is a naturally occurring, sulphur-containing amino acid derivative with potent antioxidant properties. It is primarily produced by certain fungi, mushrooms, and bacteria and is obtained by humans through dietary sources such as mushrooms and other EGT-rich foods. The ergothioneine market is segmented by form, source, application and geography. Based on form, the market is segmented into powder and liquid. Based on source, the market is segmented into mushrooms, algae, bacteria and engineered microorganisms. Based on application, the market is segmented into dietary supplements, functional food and beverages, pharmaceuticals, personal care and cosmetics, animal nutrition and other applications. By geography, the market is segmented into North America, Europe, Asia-Pacific, South America, and Middle-East and Africa. For each segment, the market sizing and forecasting have been done in value terms (USD million).

Segmentation Overview

By Form
Ergothioneine Market segmentation breakdown
Powder
Liquid
By Source
Ergothioneine Market segmentation breakdown
Mushrooms
Algae
Bacteria and Engineered Microorganisms
Yeast
By Application
Ergothioneine Market segmentation breakdown
Dietary Supplements
Functional Food and Beverages
Pharmaceuticals
Personal Care and Cosmetics
Animal Nutrition
Other Applications
By Geography
Ergothioneine Market segmentation breakdown
North America United States
Canada
Mexico
Rest of North America
Europe Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific China
India
Japan
Australia
South Korea
Rest of Asia-Pacific
South America Brazil
Argentina
Rest of South America
Middle East and Africa United Arab Emirates
South Africa
Saudi Arabia
Rest of Middle East and Africa
Ergothioneine Market segmentation breakdown
By Form Powder
Liquid
By Source Mushrooms
Algae
Bacteria and Engineered Microorganisms
Yeast
By Application Dietary Supplements
Functional Food and Beverages
Pharmaceuticals
Personal Care and Cosmetics
Animal Nutrition
Other Applications
By Geography North America United States
Canada
Mexico
Rest of North America
Europe Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific China
India
Japan
Australia
South Korea
Rest of Asia-Pacific
South America Brazil
Argentina
Rest of South America
Middle East and Africa United Arab Emirates
South Africa
Saudi Arabia
Rest of Middle East and Africa

Key Questions Answered in the Report

What is driving growth in the ergothioneine category?

Clinical research on cognitive health, sleep, mitochondrial function, and healthy aging supports demand. The global value is projected to reach USD 226.67 million by 2032 at a 15.41% CAGR.

Which ergothioneine form is growing fastest?

Liquid is projected to grow at a 16.91% CAGR through 2032, supported by ready-to-drink wellness beverages, shots, and oral beauty products.

What is the leading source of ergothioneine?

Mushrooms held 81.18% share in 2026, although bacteria and engineered microorganisms are expected to grow at 16.33% CAGR through 2032.

Which application holds the largest share of ergothioneine demand?

Dietary supplements held 41.37% share in 2026, supported by clinical evidence, established dosage forms, and consumer familiarity.

Page last updated on: